|
START is a clinical research study conducted by the Immune Tolerance Network together with researchers from eight clinical centers. The study is sponsored by the US National Institute of Allergy and Infectious Diseases, with support from the National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation. The investigators also wish to thank LifeScan, Inc. for their support of this study.
 |
|
Immune Tolerance Network
The Immune Tolerance Network is an international collaboration of researchers that conduct clinical research in new immune tolerance therapies – highly targeted treatments that prevent harmful immune responses, while leaving the protective immune response unhindered.Targeting autoimmune diseases, islet, kidney and liver transplantation and allergy and asthma the ITN is supported by the National Institute of Allergy and Infectious Diseases, the National Institutes for Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation.
www.immunotolerance.org |
| |
|
|
 |
|
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people in the United States and around the world.
www.niaid.nih.gov |
| |
|
|
 |
|
National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK, a component of the NIH, conducts and supports research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans.
www.niddk.nih.gov |
| |
|
|
 |
|
Juvenile Diabetes Research Foundation
JDRF was founded in 1970 by the parents of children with type 1 diabetes - a disease that strikes children, adolescents, and adults suddenly, makes them insulin dependent for life, and carries the constant threat of devastating complications. Since inception, JDRF has provided more than $1.16 billion to diabetes research worldwide. More than 85 percent of JDRF's expenditures directly support research and research-related education. JDRF's mission is constant: to find a cure for diabetes and its complications through the support of research.
www.jdrf.org
|
| |
|
|
|
